Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

791 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Silicon Quantum Dots: Promising Theranostic Probes for the Future.
Sivasankarapillai VS, Jose J, Shanavas MS, Marathakam A, Uddin MS, Mathew B. Sivasankarapillai VS, et al. Among authors: mathew b. Curr Drug Targets. 2019;20(12):1255-1263. doi: 10.2174/1389450120666190405152315. Curr Drug Targets. 2019. PMID: 30961492 Review.
Studies on the interaction between HSA and new halogenated metformin derivatives: influence of lipophilic groups in the binding ability.
Chaves OA, Mathew B, Parambi DGT, C S de Oliveira CH, Cesarin-Sobrinho D, Lakshminarayanan B, Najeeb S, Nafna EK, Marathakam A, Uddin MS, Joy M, Carlos Netto-Ferreira J. Chaves OA, et al. Among authors: mathew b. J Biomol Struct Dyn. 2020 Apr;38(7):2128-2140. doi: 10.1080/07391102.2019.1627247. Epub 2019 Jun 11. J Biomol Struct Dyn. 2020. PMID: 31184536
Perspective Design of Chalcones for the Management of CNS Disorders: A Mini-Review.
Mathew B, Parambi DGT, Sivasankarapillai VS, Uddin MS, Suresh J, Mathew GE, Joy M, Marathakam A, Gupta SV. Mathew B, et al. Among authors: mathew ge. CNS Neurol Disord Drug Targets. 2019;18(6):432-445. doi: 10.2174/1871527318666190610111246. CNS Neurol Disord Drug Targets. 2019. PMID: 31187716 Review.
Aptamers in Drug Design: An Emerging Weapon to Fight a Losing Battle.
Jose J, Thomas AM, Mendonsa D, Al-Sanea MM, Uddin MS, Parambi DGT, Charyulu RN, Mathew B. Jose J, et al. Among authors: mathew b. Curr Drug Targets. 2019;20(16):1624-1635. doi: 10.2174/1389450120666190729121747. Curr Drug Targets. 2019. PMID: 31362673 Review.
791 results